Quantifying HIV-1 transmission risk per-act of anal intercourse (AI) is important for HIV-1 prevention. We updated previous reviews by searching Medline and Embase to 02/2018. We derived pooled estimates of receptive AI (URAI) and insertive AI (UIAI) risk unprotected by condoms using random-effects models. Subgroup analyses were conducted by gender, study design, and whether antiretroviral treatment (ART) had been introduced by the time of the study. Two new relevant studies were identified, one of which met inclusion criteria, adding three new cohorts and increasing number of individuals/partnerships included from 1869 to 14 277. Four studies, all from highincome countries, were included. Pooled HIV-1 risk was higher for URAI (1.25%, 95% CI 0.55%-2.23%, N = 5, I 2 = 87%) than UIAI (0.17%, 95 % CI 0.09%-0.26%, N = 3, I 2 = 0%). The sole heterosexual URAI estimate (3.38%, 95% CI 1.85%-4.91%), from a study of 72 women published in a peer-reviewed journal, was significantly higher than the men-who-have-sex-with-men (MSM) pooled estimate (0.75%, 95% CI 0.56%-0.98%, N = 4, P < 0.0001) and higher than the only other heterosexual estimate identified (0.4%, 95% CI 0.08%-2.0%, based on 59 women, excluded for being a pre-2013 abstract). Pooled per-act URAI risk varied by study design (retrospectivepartner studies: 2.56%, 95% CI 1.20%-4.42%, N = 2 (one MSM, one heterosexual);
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prospective studies: 0.71%, 95% CI 0.51%-0.93%, N = 3 MSM, P < 0.0001). URAI risk was lower for studies conducted in the ART era (0.75%, 95% CI 0.52%-1.03%) than pre-ART (1.67%, 95% CI 0.44%-3.67%) but not significantly so (P = 0.537). Prevention messages must emphasize that HIV-1 infectiousness through AI remains high, even in
| INTRODUC TI ON
Anal intercourse (AI) drives HIV-1 epidemics among men-who-havesex-with-men (MSM), and numerous studies have demonstrated that substantial proportions of heterosexual populations also practise AI, 1,2 potentially making it an important source of heterosexual HIV-1 transmission. 3 Quantifying the role of AI in HIV-1 epidemics is important for effective targeting of safe sex messages, for developing and implementing HIV-1 prevention technologies, and to inform mathematical models. Two previously published systematic reviews and meta-analyses have only included four studies providing estimates of the probability of HIV-1 transmission per AI act unprotected by condoms. the review to February 2012, and derived a similar pooled estimate to Baggaley et al despite excluding a study 6 
included in
Baggaley et al 5 and incorporating one new study (1.38%, 95% CI 1.02%-1.86%). 7 Patel also reported a pooled estimate for insertive AI unprotected by condoms (UIAI): 0.1% (95% CI 0.0%-0.3%).
However, since their search, additional per-act estimates derived from large HIV-1 cohort datasets have been published. 8, 9 Given the scarce data on per-act AI HIV risk, it is important to update pooled estimates in the light of new data, to reduce uncertainty and provide more reliable estimates to address public health questions and for use in models. 
| ME THODS
The systematic review and meta-analysis were conducted in accordance with the PRISMA statement. 
| Search strategy
We conducted literature searches to identify new studies reporting data on per-act HIV-1 transmission risk through anal intercourse 
| Study selection
Inclusion criteria were randomized controlled trials, longitudinal studies (prospective or retrospective) or other empirical observational studies that directly reported estimates of per-act HIV-1 transmission risk through AI. We excluded studies that did not stratify AI risk, receptive vs insertive. Abstracts pre-2013, studies using sample sizes less than 10, and estimates derived from dynamic transmission modelling studies fitted to empirical HIV-1 prevalence curves, were excluded. While we included studies where study populations included individuals using ART, we aimed to include "real life the ART era. Further studies, particularly among heterosexual populations and in resource-limited settings, are required to elucidate whether AI risk differs by gender, region and following population-level ART scale-up.
K E Y W O R D S
anal intercourse, antiretroviral therapy, heterosexual, HIV, infectivity, meta-analysis, MSM, review, transmission probability studies" only, and so excluded studies where successful, suppressive ART of index partners was an inclusion criterion. Abstracts and other unpublished data older than 5 years were excluded because they were unlikely to result in peer-reviewed publication. There was no restriction by study year, region, or language of publication. AI per-act estimates included in previous systematic reviews, 4 ,5 which we refer to as "original estimates", were included if they fulfilled the current inclusion criteria.
| Data extraction
Study review was conducted independently by two separate authors (RFB and BNO). Data were extracted on the following study and participant characteristics: region, study design, study dates, 
| Statistical methods
We performed random-effects inverse-variance meta-analysis 11 on arcsin-transformed study estimates, which were backtransformed to the original scale to produce pooled estimates for per-act risk of HIV-1 transmission through URAI and UIAI. We presented available study estimates and pooled URAI and UIAI estimates in forest plots.
Meta-regression and subgroup analysis were used to explore potential sources of heterogeneity: gender; study design, for example, retrospective-partner study, prospective cohort of individuals; and ART use among partners. We assessed the robustness of pooled estimates and the influence of each individual study using leave-oneout sensitivity analysis (ie, an influence analysis 11 ). We also assessed the influence of relaxing our inclusion criteria to include Halperin et al 6 (0.4%, 95% CI 0.08%-2.0%, excluded for being unpublished data pre-2013). Heterogeneity across study estimates was assessed using I 2 statistics. Analysis was performed using R version 3.4. 2 12 and the metafor package.
| RE SULTS

| Search results
Of 5336 unique studies published from February 2012 to February 2018 that we identified in our online searches, 4985 were excluded for nonrelevance based on the title, and 349 excluded based on the abstract or full text. Two new articles directly reported per-act HIV-1 transmission probability estimates. 8, 9 No study had been excluded from our previous review based on ART use. Figure 1 illustrates the study selection procedure. 
| Studies included in each systematic review
| Study characteristics
Five URAI per-act study estimates reported by four studies 7, 8, 19, 20 and three UIAI estimates reported by two studies 7, 8 were included estimates for prehighly active antiretroviral therapy (HAART, hereafter referred to as ART: study data from 1992-1995) and early ART (study data from 1995-2003) eras, for both URAI and UIAI, because they combined data from four cohorts. [13] [14] [15] [16] [17] Data collection occurred between 1987 and 2007, although the earliest included publication did not state study dates. 19 URAI study estimates used data from Australia (N = 1 7 ), the United States (N = 3 8, 19 ) and one multi-European country study 20 (Table 1) . UIAI study estimates used data from Australia (N = 1 7 ) and the United States (N = 2
19
). All but one included study estimate (Leynaert et al 20 , URAI) used data from MSM populations ( Figure 2 ). Two URAI study estimates were from retrospective-partner studies 19, 20 ; the remaining three used data from prospective cohorts of individuals.
7,8
Three URAI study estimates used face-to-face interview (FTFI) No studies reported on ART use of index partners. These data were not available from cohorts of individuals because they cannot be collected using this design. 15 ). g Data mentioned in text but not included in meta-analysis. h Data taken from the EXPLORE study, 13 restricted to study participants reporting never using condoms. i Data taken from the VAX 004 study, 14 restricted to study participants reporting never using condoms. 
TA B L E 1 (Continued)
| Meta-analysis results
The updated pooled estimate of per-act URAI HIV-1 risk of 1.25%
(95% CI 0.55%-2.23%, N = 5, I 2 = 87%) 7, 8, 19, 20 was considerably and statistically significantly higher (P = 0.0026) and more heterogeneous than the UIAI risk (0.17%, 95% CI 0.09%-0.26%, I 2 = 0%, N = 3 7, 8 ). Pooled and study estimates are shown in Figure 2 . ART, antiretroviral treatment; N, number of study estimates; NA, not applicable; P, P-value; Q, heterogeneity statistic; UIAI, unprotected insertive anal intercourse; URAI, unprotected receptive anal intercourse. a "P" is the P-value for heterogeneity of the pooled estimate; "P-value" is the meta-regression P-value defining the significance of the difference in pooled estimates between the two subgroups. from the MSM estimate (P = 0.370, Figure S1 ). MSM per-act estimates for both URAI and UIAI showed relatively little heterogeneity (I 2 < 0.1%).
| Subgroup analysis
Pooled per-act URAI risk from studies where ART was likely to have been used by >0% of sexual partners was lower than half (0.75%, 95% CI 0.52%-1.03%, N = 2) that without ART use (1.67%, 95% CI 0.44%-3.67%, N = 3) but this difference was not significant (P = 0.537). Per-act UIAI risks were similar by ART use (0.14%, 95%
CI 0.04%-0.29% for 0% use vs 0.18%, 95% CI 0.09%-0.31% for >0%
use, P = 0.955). When assessed in multivariate meta-regression analysis, only study design was (borderline) significantly associated with magnitude of URAI transmission risk (P = 0.055), accounting for >99% of the heterogeneity across study estimates (R 2 = 99.9%).
Meta-regression analysis could not be undertaken for UIAI given the small number of estimates (N = 3, all from MSM populations).
| Sensitivity analysis
In the leave-one-out sensitivity analysis, only the omission of the heterosexual URAI estimate from Leynaert et al 20 among heterosexual couples substantially reduced heterogeneity (I 2 reduced from 87% to 0%), producing an all-MSM pooled URAI estimate (0.75%, 95% CI 0.56%-0.98%) ( Figure S1 ). Adding the Halperin et al 6 study
estimate did not substantially influence the URAI pooled estimate (1.10%, 95% CI 0.50%-1.94%, I 2 = 85%, Figure S1 ). The pooled UIAI estimate was also not affected by any individual study estimate because study estimates were remarkably homogeneous ( Figure 2 , for UIAI), and raises the question of whether HIV risk during URAI is higher for women than MSM, also highlighting the lack of data from resource-limited settings.
| D ISCUSS I ON
Our new pooled estimate is slightly lower than the previous pooled URAI estimates by Baggaley et al 5 and Patel et al 4 , and a slight, nonsignificant increase on the previous pooled UIAI estimate reported by Patel et al 4 We have explored sources of heterogeneity as far as possible, given the few included study estimates. In fact, URAI and UIAI estimates from MSM study populations were remarkably homogeneous (I 2 = 0%). It is unclear whether gender or study design accounted for the heterogeneity across all URAI study estimates, but even after omitting the highest URAI estimate (ie, the sole heterosexual estimate, 20 see Figure S1 ), the estimate of HIV-1 transmission risk through URAI remained high (0.75%, 95%
CI 0.56%-0.98%). Even considering only study estimates which were conducted since the introduction of ART, risk remained nearly 10-fold riskier than unprotected receptive vaginal intercourse (VI):
URAI 0.75%, 95% CI 0.52%-1.03% vs unprotected receptive VI:
0.08%, 95% CI 0.06%-0.11%. 21 UIAI risk in the ART era is more than fourfold riskier than insertive VI (0.18%, 95% CI 0.09%-0.31% vs 0.04%, 95% CI 0.01%-0.14% 21 ).
It is unclear why the Leynaert et al 20 URAI risk among females was so high (3.38%, 95% CI 1.85%-4.91%). All studies were conducted in industrialized countries, so difference by region is unlikely.
Heterosexual study participants reported monogamy and no STIs.
However, a large proportion of index cases (65% of the entire sam- Qualitative research has suggested that heterosexual AI often occurs without the explicit prior consent of women.
27,28
Our meta-regression found the pooled URAI risk among studies conducted in the ART era, when there was likely to be >0% ART use among sexual partners of study participants, was less than half that from pre-ART studies, but this difference failed to reach statistical significance, probably partly because of the small number of estimates and also the variability across estimates in the pre-ART era (from 0.60% 8 to 3.38% 20 ). For both URAI and UIAI, Scott et al pre-ART and early ART era per-act study estimates were very similar. Scott et al explained this lack of a significant association by suggesting that a relatively low proportion of infected MSM were on ART and had a suppressed viral load during the years in which data were collected. There are some limitations to our findings, mainly due to scarcity of data. The few study estimates prevent us from exploring the sources of heterogeneity in greater depth. Only one heterosexual study estimate was included, so it is difficult to know if differences in infectiousness by gender are real or confounded by study design. Different studies have used different statistical techniques to attempt this. All but one study used FTFI to gather sexual behaviour data, which may lead to social desirability bias. 30 These limitations may over-or underestimate per-act risk, and together with the small number of studies identified, and the variation in methods of data analysis, mean we recommend further data gathering using more confidential techniques such as ACASI, and analysis using standardized statistical methods, to increase comparability of studies and robustness of pooled estimates. Publication bias and selective reporting are likely to be low, because these studies are not assessing significance or effectiveness outcomes. This bias could be investigated using funnel plots if more study estimates became available.
In conclusion, current evidence suggests that practising unpro- 
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